Medicare Enrolled

Dr. Abhilasha Patel, M.D.

Internal Medicine · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
925 GESSNER RD STE 100, Houston, TX 77024
7132423500
Registered in NPPES since 2009
NPI: 1649405382 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Abhilasha Patel is an internal medicine specialist in Houston, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 10,745 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Patel received a total of $86,381 from 40 pharmaceutical and/or device companies across 197 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration ▲ Top 3% volume in TX $86,381 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
10,745
Medicare services
Top 3% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
7,473 $0 $3
CT guidance for radiation therapy
This procedure uses computed tomography imaging to guide the precise placement of radiation therapy fields. It ensures accurate positioning for targeted treatment delivery.
1,121 $96 $596
Intensity-modulated radiation therapy delivery
Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session.
774 $277 $2,762
Continuing radiation therapy consultation per week
A weekly consultation to review and manage ongoing radiation therapy treatment.
232 $70 $343
Calculation of radiation therapy dose 219 $52 $365
Radiation treatment management, 5 sessions
Oversight and management of a radiation therapy course consisting of five treatment sessions.
219 $155 $1,067
Design and construction of radiation treatment device
This code covers the design and construction of a device used for high precision radiation therapy. It does not include the actual administration of radiation treatment.
77 $361 $2,640
Cranial lesion radiation therapy
Treatment of a brain lesion using radiation delivered over multiple sessions.
70 $811 $8,210
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
61 $98 $368
High precision radiation therapy planning
This procedure involves the detailed planning and setup required for delivering high-precision radiation therapy to a target area of the body.
59 $1,462 $6,431
New patient office visit, complex (60-74 min) 59 $171 $709
Complex radiation therapy planning 58 $134 $1,022
Design and construction of complex radiation treatment device
This code covers the design and construction of a complex radiation treatment device. It does not specify the clinical purpose or conditions treated.
58 $99 $710
CT scan of abdomen and pelvis with contrast
A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas.
53 $173 $1,067
CT scan of chest with contrast
A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures.
51 $44 $821
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $71 $250
CT scan of abdomen and pelvis, without contrast
A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye.
40 $81 $560
Special radiation treatment 36 $113 $1,794
Fractionated radiation therapy for cranial lesion
Treatment using radiation delivered in multiple sessions to manage a lesion in the head.
16 $521 $3,609
Respiratory data collection for radiation therapy planning
This procedure involves gathering respiratory data to help develop the optimal radiation treatment plan.
15 $334 $1,838
CT scan of abdomen and pelvis with contrast
A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures.
11 $211 $1,413
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$86,381
Total received (2018-2024)
Avg $12,340/year across 7 years
Top 2% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
197
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$887
2023
$7,104
2022
$9,028
2021
$5,052
2020
$14,751
2019
$37,955
2018
$11,603

Payments by company (2024)

Myriad Genetic Laboratories, Inc.
$254
Bayer Healthcare Pharmaceuticals Inc.
$113
PFIZER INC.
$67
Novartis Pharmaceuticals Corporation
$54
Deciphera Pharmaceuticals Inc.
$53
SOBI, INC
$52
Eisai Inc.
$49
Regeneron Healthcare Solutions, Inc.
$48
Janssen Biotech, Inc.
$40
Merck Sharp & Dohme LLC
$34
AstraZeneca Pharmaceuticals LP
$26
Rigel Pharmaceuticals, Inc.
$23
Boston Scientific Corporation
$23
EMD Serono, Inc.
$18
Incyte Corporation
$17
Genentech USA, Inc.
$16
Top 3 companies account for 48.9% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$77,726
Bayer Healthcare Pharmaceuticals Inc.
$6,299
Tactile Systems Technology Inc
$323
Novartis Pharmaceuticals Corporation
$262
Myriad Genetic Laboratories, Inc.
$254
Abbott Laboratories
$145
Clovis Oncology, Inc.
$125
Lilly USA, LLC
$119
Amgen Inc.
$105
PFIZER INC.
$85
Merck Sharp & Dohme LLC
$82
Janssen Biotech, Inc.
$73
Janssen Pharmaceuticals, Inc
$64
Eisai Inc.
$63
Deciphera Pharmaceuticals Inc.
$53
SOBI, INC
$52
Regeneron Healthcare Solutions, Inc.
$48
AstraZeneca Pharmaceuticals LP
$42
Exelixis Inc.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$33
Sumitomo Pharma America, Inc.
$27
Daiichi Sankyo Inc.
$26
Stemline Therapeutics Inc.
$26
Axonics, Inc.
$26
Rigel Pharmaceuticals, Inc.
$23
Boston Scientific Corporation
$23
Blue Earth Diagnostics Limited
$22
Kyowa Kirin, Inc.
$20
Seagen Inc.
$19
EMD Serono, Inc.
$18
TerSera Therapeutics LLC
$18
Incyte Corporation
$17
JAZZ PHARMACEUTICALS INC.
$17
Mirati Therapeutics, Inc.
$17
Genentech USA, Inc.
$16
PORTOLA PHARMACEUTICALS, INC.
$16
Tolmar, Inc.
$16
Telix Pharmaceuticals
$16
TherapeuticsMD, Inc.
$14
Dendreon Pharmaceuticals LLC
$12
Top 3 companies account for 97.6% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · Alecensa · Axonics · Axumin · Cabometyx · ELIGARD · ENHERTU · ERLEADA · Enhertu · Flexitouch Plus · ILLUCCIX · IMLYGIC · IMVEXXY · INLYTA · KEYTRUDA · KRAZATI · LIBTAYO · Lenvima · MEKINIST · MITRACLIP · MONJUVI · MYRISK · NINLARO · Nubeqa · ORGOVYX · Orserdu · PADCEV · PLUVICTO · PROLARIS · PROVENGE · Poteligeo · QINLOCK · Quzyttir · RYBREVANT · Rezlidhia · Rubraca · TAFINLAR · TAGRISSO · TheraSphere Y90 Glass Microspheres 10 GBq · VERZENIO · VONJO · XARELTO · XTANDI · Xofigo · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an internal medicine specialist in Houston?
Compare internal medicine physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians in nearby ZIP areas
2,638
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Patel performed 7,473 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $86,381 from 40 companies across 197 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other internal medicine physicians in Houston?
Dr. Patel's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →